OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (CovovaxTM) after homologous and heterologous two-dose regimens
Sitthichai Kanokudom, Jira Chansaenroj, Nungruthai Suntronwong, et al.
International Journal of Infectious Diseases (2022) Vol. 126, pp. 64-72
Open Access | Times Cited: 15

Showing 15 citing articles:

Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants
Kirsten E. Lyke, Robert L. Atmar, Clara Domínguez Islas, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 20

Structural understanding of SARS-CoV-2 virus entry to host cells
Kim Le, Shrute Kannappan, Truc Kim, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 10

Editorial: COVID-19 booster vaccination: increasing immunity against life-threatening infection
Ritthideach Yorsaeng, Kamolthip Atsawawaranunt, Abanoub Riad
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 2

Immunogenicity and Safety of SARS-CoV-2 Protein Subunit Recombinant Vaccine (IndoVac®) as a Booster Dose against COVID-19 in Indonesian Adults
Kusnandi Rusmil, Eddy Fadlyana, Rodman Tarigan Girsang, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 540-540
Open Access | Times Cited: 2

The Fourth Dose of mRNA COVID-19 Vaccine Following 12 Different Three-Dose Regimens: Safety and Immunogenicity to Omicron BA.4/BA.5
Sitthichai Kanokudom, Jira Chansaenroj, Nungruthai Suntronwong, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 570-570
Open Access | Times Cited: 6

Pivoting to protein: the immunogenicity and safety of protein-based NVX-CoV2373 as a heterologous booster for inactivated and viral vector COVID-19 vaccines
Anthony M. Marchese, Raj Kalkeri, Muruga Vadivale, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 620-628
Open Access | Times Cited: 5

Evaluation of the Efficacy of BBIBP-CorV Inactivated Vaccine Combined with BNT62b2 mRNA Booster Vaccine
Éva Rákóczi, Gusztáv Magócs, Sára Kovács, et al.
Diagnostics (2023) Vol. 13, Iss. 3, pp. 556-556
Open Access | Times Cited: 3

Humoral response after a BNT162b2 heterologous third dose of COVID-19 vaccine following two doses of BBIBP-CorV among healthcare personnel in Peru
Stephanie Montero, Diego Urrunaga‐Pastor, Percy Soto-Becerra, et al.
Vaccine X (2023) Vol. 14, pp. 100311-100311
Open Access | Times Cited: 3

Real-World Study: Hybrid Immunity against SARS-CoV-2 Influences the Antibody Levels and Persistency Lasting More than One Year
Sitthichai Kanokudom, Jira Chansaenroj, Suvichada Assawakosri, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1693-1693
Open Access | Times Cited: 3

Evaluation of Anti-S1 IgA Response to Different COVID-19 Vaccination Regimens
Teeraporn C. Bureerug, Sitthichai Kanokudom, Nungruthai Suntronwong, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1117-1117
Open Access | Times Cited: 2

Prognostic Factors Associated with the Severe Course of a New Coronavirus Infection
Yu. B. Khamanova, Т. A. Frayfeld, K. R. Mullagalieva, et al.
Ural Medical Journal (2024) Vol. 23, Iss. 1, pp. 129-140
Open Access

Unraveling COVID-19: A Global Health Crisis and Ongoing Research
Osama Alam, Muhammad Ahmad, Munib Qureshi, et al.
Futuristic Biotechnology (2023), pp. 10-18
Open Access | Times Cited: 1

Functional foods as immunomodulators: Tackling the SARS-CoV-2 related cytokine storm–A review
Harshdeep Kaur, Minni Singh
Food Chemistry Advances (2023) Vol. 3, pp. 100407-100407
Open Access

Page 1

Scroll to top